Mechanisms of coronary dysfunction in obesity and insulin resistance

Jarrod D. Knudson, U. Deniz Dincer, Ian N. Bratz, Michael Sturek, Gregory M. Dick, Johnathan Tune

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The incidence of obesity and the metabolic syndrome has reached epidemic proportions and alterations in coronary microvascular function could contribute to the increased cardiovascular morbidity and mortality observed in these patients. This review highlights key mechanisms of impaired control of coronary blood flow in the metabolic syndrome. Specifically, coronary endothelial dysfunction, altered neurohumoral control, and the potential roles of smooth muscle ion channels are addressed. Recent studies indicate that alterations in endothelial-dependent vasodilation or endothelial-dependent vasoconstriction contribute little to obesity-induced impairments in coronary vascular control. In contrast, augmented vasoconstriction in response to neurohumoral mediators appears to play a significant role in coronary vascular dysfunction. The authors conclude that coronary dysfunction in the metabolic syndrome is characterized by an imbalance between coronary blood flow and myocardial metabolism that may be mediated by sensitization of vasoconstrictor pathways. Further, they suggest that alterations in smooth muscle ion channels, Ca2+ handling, and cell signaling may be important mechanisms leading to coronary microvascular dysfunction. Importantly, however, more research is needed to clearly delineate specific mechanisms and identify potential therapeutic targets.

Original languageEnglish
Pages (from-to)317-338
Number of pages22
JournalMicrocirculation
Volume14
Issue number4-5
DOIs
StatePublished - Jun 2007

Fingerprint

Insulin Resistance
Obesity
Vasoconstriction
Ion Channels
Smooth Muscle
Blood Vessels
Vasoconstrictor Agents
Vasodilation
Morbidity
Mortality
Incidence
Research
Therapeutics

Keywords

  • Coronary circulation
  • Metabolic syndrome
  • Metabolic vasodilation
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Physiology
  • Genetics
  • Cardiology and Cardiovascular Medicine

Cite this

Mechanisms of coronary dysfunction in obesity and insulin resistance. / Knudson, Jarrod D.; Dincer, U. Deniz; Bratz, Ian N.; Sturek, Michael; Dick, Gregory M.; Tune, Johnathan.

In: Microcirculation, Vol. 14, No. 4-5, 06.2007, p. 317-338.

Research output: Contribution to journalArticle

Knudson, Jarrod D. ; Dincer, U. Deniz ; Bratz, Ian N. ; Sturek, Michael ; Dick, Gregory M. ; Tune, Johnathan. / Mechanisms of coronary dysfunction in obesity and insulin resistance. In: Microcirculation. 2007 ; Vol. 14, No. 4-5. pp. 317-338.
@article{92c6a15fc3434fe0bb224aec39ab5476,
title = "Mechanisms of coronary dysfunction in obesity and insulin resistance",
abstract = "The incidence of obesity and the metabolic syndrome has reached epidemic proportions and alterations in coronary microvascular function could contribute to the increased cardiovascular morbidity and mortality observed in these patients. This review highlights key mechanisms of impaired control of coronary blood flow in the metabolic syndrome. Specifically, coronary endothelial dysfunction, altered neurohumoral control, and the potential roles of smooth muscle ion channels are addressed. Recent studies indicate that alterations in endothelial-dependent vasodilation or endothelial-dependent vasoconstriction contribute little to obesity-induced impairments in coronary vascular control. In contrast, augmented vasoconstriction in response to neurohumoral mediators appears to play a significant role in coronary vascular dysfunction. The authors conclude that coronary dysfunction in the metabolic syndrome is characterized by an imbalance between coronary blood flow and myocardial metabolism that may be mediated by sensitization of vasoconstrictor pathways. Further, they suggest that alterations in smooth muscle ion channels, Ca2+ handling, and cell signaling may be important mechanisms leading to coronary microvascular dysfunction. Importantly, however, more research is needed to clearly delineate specific mechanisms and identify potential therapeutic targets.",
keywords = "Coronary circulation, Metabolic syndrome, Metabolic vasodilation, Vascular smooth muscle",
author = "Knudson, {Jarrod D.} and Dincer, {U. Deniz} and Bratz, {Ian N.} and Michael Sturek and Dick, {Gregory M.} and Johnathan Tune",
year = "2007",
month = "6",
doi = "10.1080/10739680701282887",
language = "English",
volume = "14",
pages = "317--338",
journal = "Microcirculation",
issn = "1073-9688",
publisher = "Wiley-Blackwell",
number = "4-5",

}

TY - JOUR

T1 - Mechanisms of coronary dysfunction in obesity and insulin resistance

AU - Knudson, Jarrod D.

AU - Dincer, U. Deniz

AU - Bratz, Ian N.

AU - Sturek, Michael

AU - Dick, Gregory M.

AU - Tune, Johnathan

PY - 2007/6

Y1 - 2007/6

N2 - The incidence of obesity and the metabolic syndrome has reached epidemic proportions and alterations in coronary microvascular function could contribute to the increased cardiovascular morbidity and mortality observed in these patients. This review highlights key mechanisms of impaired control of coronary blood flow in the metabolic syndrome. Specifically, coronary endothelial dysfunction, altered neurohumoral control, and the potential roles of smooth muscle ion channels are addressed. Recent studies indicate that alterations in endothelial-dependent vasodilation or endothelial-dependent vasoconstriction contribute little to obesity-induced impairments in coronary vascular control. In contrast, augmented vasoconstriction in response to neurohumoral mediators appears to play a significant role in coronary vascular dysfunction. The authors conclude that coronary dysfunction in the metabolic syndrome is characterized by an imbalance between coronary blood flow and myocardial metabolism that may be mediated by sensitization of vasoconstrictor pathways. Further, they suggest that alterations in smooth muscle ion channels, Ca2+ handling, and cell signaling may be important mechanisms leading to coronary microvascular dysfunction. Importantly, however, more research is needed to clearly delineate specific mechanisms and identify potential therapeutic targets.

AB - The incidence of obesity and the metabolic syndrome has reached epidemic proportions and alterations in coronary microvascular function could contribute to the increased cardiovascular morbidity and mortality observed in these patients. This review highlights key mechanisms of impaired control of coronary blood flow in the metabolic syndrome. Specifically, coronary endothelial dysfunction, altered neurohumoral control, and the potential roles of smooth muscle ion channels are addressed. Recent studies indicate that alterations in endothelial-dependent vasodilation or endothelial-dependent vasoconstriction contribute little to obesity-induced impairments in coronary vascular control. In contrast, augmented vasoconstriction in response to neurohumoral mediators appears to play a significant role in coronary vascular dysfunction. The authors conclude that coronary dysfunction in the metabolic syndrome is characterized by an imbalance between coronary blood flow and myocardial metabolism that may be mediated by sensitization of vasoconstrictor pathways. Further, they suggest that alterations in smooth muscle ion channels, Ca2+ handling, and cell signaling may be important mechanisms leading to coronary microvascular dysfunction. Importantly, however, more research is needed to clearly delineate specific mechanisms and identify potential therapeutic targets.

KW - Coronary circulation

KW - Metabolic syndrome

KW - Metabolic vasodilation

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=34447308751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447308751&partnerID=8YFLogxK

U2 - 10.1080/10739680701282887

DO - 10.1080/10739680701282887

M3 - Article

VL - 14

SP - 317

EP - 338

JO - Microcirculation

JF - Microcirculation

SN - 1073-9688

IS - 4-5

ER -